Condition
Opiod Use Disorder
Total Trials
5
Recruiting
2
Active
2
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
50%
1 of 2 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (2)
P 1 (2)
Trial Status
Recruiting2
Completed2
Not Yet Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07457489Not ApplicableRecruitingPrimary
Vanderbilt Integrated Community TMS for Opioid Recovery
NCT07498322Not ApplicableNot Yet RecruitingPrimary
Chicago Data-driven Opioid Use Disorder Screening, Engagement, Treatment and Planning System
NCT07085351RecruitingPrimary
EEG Biomarkers for OUD: Diagnostic, Prognostic, and Predictive Applications
NCT05304364Phase 1CompletedPrimary
Safety, Tolerability, and Pharmacokinetics of Naltrexone Implant (DLP-160)
NCT03831971Phase 1CompletedPrimary
The Influence of ANS-6637 on Midazolam Pharmacokinetics in Healthy Volunteers
Showing all 5 trials